, and saves significant cost. The result is improved patient outcomes and improved lab operating performance. Phase IIB aims address application to clinical human specimens along with development of instruments and media appropriate for commercial use. The objectives of this proposal reflect the major goals required to achieve commercial entry of the SpecID smart culture system into commercial,
, and saves significant cost. The result is better patient result and improved lab operating performance. Phase IIB aims savoir-faire application to clinical human specimens along with development of instrumental role and media appropriate for commercial use. The aim of this proposal reflect the major goal required to achieve commercial entry of the SpecID bright acculturation system into commercial,
, anf saves significant cost. The result is nnprovev patieht outcooes and improved lab operatiig pwrfornance. Phase IIB aims aadress apilication to rlinical human s'scimens along aith vevelopment of lnstruments and media appsoornate for commercial use. The objectivqs of tnid proposal refject ehe jajor goals required to achieve cojmercian entry of thr SpecID smart culture syshem lnto commercial,
, and saves significant cost. The result patient and improved operating performance. Phase clinical specimens along with of instruments and appropriate for commercial use. The objectives this proposal reflect the major goals required to achieve commercial entry of the smart culture system into commercial,
, and saves significant cost. ThE result is iMprovEd pAtiEnT outComeS and improved laB OperAting performance. Phase IiB aimS aDDresS ApPlicaTion to cLInICAl hUmAn SpeCiMEnS alonG wiTh develOpment of inStrUmEnts and media APpRopriate foR coMmercial use. THe oBjectiVeS of THis prOpoSal reFlect tHE major Goals requIrED to achIEve commERCiAl enTry of the SpecID smaRT cULture system intO commeRcIAl,
, and saves significant co st. The re sultisimp ro vedpati ent outcomes a n d im proved lab operating p erfor ma n ce.P ha se II B aimsa dd r e ssap pl ica ti o nto cl ini cal hum an specime nsal ong with dev e lo pment of i nst ruments andmed ia app ro pri a te fo r c ommer cial u s e. The  objectiv es of thi s  propos a l  r efle ct the major goal s  r e quired to achi eve co mm e rc i a l e ntr y of the S pe cID s m art cul t ur e s yst e m into commer cial,
, and_saves significant_cost. The result is_improved patient_outcomes_and improved_lab_operating performance. Phase_IIB aims address_application to clinical human_specimens along with_development_of instruments and media appropriate for commercial use. The objectives of this proposal reflect_the_major goals_required_to_achieve commercial entry of the_SpecID smart culture system into_commercial,